Navigation Links
First Cognitive Training to Demonstrate Immediate Generalizability Through Standardized Assessments of Memory
Date:11/19/2007

SAN FRANCISCO, Nov. 19 /PRNewswire/ -- Preliminary data from the IMPACT study are being presented today at the Gerontological Society of America's annual conference. The purpose of the IMPACT ("Improvement in Memory with Plasticity-based Adaptive Cognitive Training") study was to evaluate whether improvements from cognitive training can extend to untrained measures of memory performance and to self-perceived everyday cognition.

The IMPACT trial compares the benefits of a plasticity-based cognitive training program (the Posit Science Brain Fitness Program) to a computer-based learning control matched for computer usage and training intensity. It was chosen to represent current clinical recommendations regarding "staying cognitively active." The IMPACT study is the first large-scale randomized controlled trial of a non-invasive, computer-based cognitive intervention for aging adults that is available for widespread, individual use. In addition to using standardized neuropsychological tests to assess training-related changes in memory, the IMPACT study measured the improvements in cognitive abilities directly reported by study participants themselves.

Using an intensive series of adaptive computerized exercises, the Brain Fitness Program is designed to target the speed and accuracy of auditory and language processes, and neuromodulatory systems associated with learning and memory. Predefined endpoints distinct in design and content from training exercises included standardized neuropsychological assessments of memory and participant-reported outcome (PRO) assessments measuring perceptions of everyday cognition.

After 10 weeks of training, significant group by time interactions favoring the experimental group (the Brain Fitness Program) were seen on the primary endpoint measure (RBANS Auditory Memory) and multiple within-modality but not cross-modality secondary endpoint measures. PRO measures of everyday cognitive function were significant on pre-post and post-only assessments.

Principal Investigators Glenn Smith, PhD at Mayo Clinic and Elizabeth Zelinski, PhD at the University of Southern California, participated in this prospective, randomized, controlled trial. The study involved 524 healthy adults over the age of 65.

About Posit Science

Posit Science Corporation develops science-based brain health programs. The company works with more than 50 brain scientists from leading universities around the world to create training programs that enhance cognitive performance. Its assessments and exercises are based on neuroplasticity -- the brain's ability to "rewire" through intensive, repetitive and progressively challenging activity. The company's Brain Fitness Program is distributed without charge by Humana to its Medicare Advantage members, is licensed to more than 150 retirement communities nationwide, is sold online and by Authorized Providers. Posit Science has received several grants from the National Institutes of Health (NIH). Posit Science was named "Best Small Company" by the American Society on Aging, was named "Best Fitness Initiative" by the Consumer Health World Conference and was selected as one of the "medical breakthroughs of the year" by CNBC. For more information visit http://www.PositScience.com or call 800.514.3975.


'/>"/>
SOURCE Posit Science Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Tel Aviv (PRWEB) , ... May 31, 2016 ... ... in the May 4, 2016 Cool Vendors in Security Infrastructure Protection report by ... areas and publishes a series of research reports evaluating these innovative vendors and ...
(Date:5/31/2016)... PLAINSBORO, N.J. (PRWEB) , ... May 31, 2016 ... ... digital and print media enterprise focused on patients with cancer, has added ... provide readers and website visitors with more timely content on continuing successful careers ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the leader in ... original infographic, " Health Benefits Reimbursement Compliance Timeline ." , The new ... with various federal regulations and reforms. , Navigating the new health reforms can ...
(Date:5/29/2016)... ... 29, 2016 , ... Whole Health Supply is happy to announce a new ... available to the public. This is an unusual clipper because it opens to a ... , Everything about this product is concentrated on ease of use, functionality and durability. ...
(Date:5/28/2016)... ... ... May 26, 2016- In search of the K. Warriors, Shaolin Institute is ... Warriors” on June 4, 2016 at Ashbury Hotel and Suites 600 West Interstate 65 ... by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is the 28th ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 31, 2016 RnRMarketResearch.com adds "Asthma ... comparative analysis of Asthma therapy at various stages, therapeutics ... of administration (RoA) and molecule type, along with latest ... reviews key players involved in the therapeutic development for ... Complete report on H1 2016 pipeline review ...
(Date:5/30/2016)... 30, 2016 On 28 May, 194 ... by 2030. At the 69 th World Health Assembly, ... Hepatitis Strategy, signalling the greatest global commitment in viral hepatitis ... eliminating hepatitis B and C by 2030 and includes a ... reduce annual deaths by 65% and increase treatment to 80%, ...
(Date:5/27/2016)... LabStyle Innovations Corp . ( NASDAQ: DRIO ... that the Company,s Chief Financial Officer, Zvi Ben-David ... 1-2 in New York, NY and ... Los Angeles, CA. During his ... including the U.S. FDA Clearance and commercial launch of the ...
Breaking Medicine Technology: